The University of Mississippi Medical Center (UMC) Pediatric Oncology Division utilizes the cooperative studies of the Pediatric Oncology Group (POG) as the basis for its clinical and laboratory research programs. The UMC's participation in the POG incorporates multidisciplinary input, both locally and on POG committees. Participating disciplines include: pediatric medical oncology (chemotherapy), pediatric surgery, pediatric pathology, radiation therapy, immunology, and cytogenetics. The POG's central objective is the delineation of increasingly effective means for treating various types of childhood malignancies using the cooperative efforts of the 39 participating institutions in treatment protocol design and implementation and in performing ancillary laboratory research studies. Studies are currently planned or in progress for acute lymphocytic leukemia, acute granulocytic leukemia, Hodgkin's disease, non-Hodgkin's lymphoma, histiocytosis X, Wilms' tumor, neuroblastoma, rhabdomyosarcoma, osteogenic sarcoma, Ewing's sarcoma, brain tumor and germ cell tumor. The UMC is participating actively in POG committee functions and protocol development. The UMC principal investigator is serving as chairman of the New ALL Committee. The UMC is serving as the coordinating institution for the pilot and final ALinC (Acute Leukemia in Children) 13 classification and treatment protocols (POG 7865, 7866, 8035, and 8036) and also as the coordinating institution or the T-cell leukemia portion of the POG 7615 protocol.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10CA015989-11
Application #
3556344
Study Section
Cancer Clinical Investigation Review Committee (CCI)
Project Start
1979-01-01
Project End
1986-01-31
Budget Start
1985-01-01
Budget End
1986-01-31
Support Year
11
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Mississippi Medical Center
Department
Type
Schools of Medicine
DUNS #
928824473
City
Jackson
State
MS
Country
United States
Zip Code
39216
Wacker, Pierre; Land, Vita J; Camitta, Bruce M et al. (2007) Allergic reactions to E. coli L-asparaginase do not affect outcome in childhood B-precursor acute lymphoblastic leukemia: a Children's Oncology Group Study. J Pediatr Hematol Oncol 29:627-32
Whitehead, V M; Shuster, J J; Vuchich, M J et al. (2005) Accumulation of methotrexate and methotrexate polyglutamates in lymphoblasts and treatment outcome in children with B-progenitor-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. Leukemia 19:533-6
Shamberger, Robert C; LaQuaglia, Michael P; Gebhardt, Mark C et al. (2003) Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy. Ann Surg 238:563-7; discussion 567-8
Goorin, Allen M; Harris, Michael B; Bernstein, Mark et al. (2002) Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial. J Clin Oncol 20:426-33
Winter, S S; Sweatman, J; Shuster, J J et al. (2002) Bone marrow stroma-supported culture of T-lineage acute lymphoblastic leukemic cells predicts treatment outcome in children: a Pediatric Oncology Group study. Leukemia 16:1121-6
Mahoney Jr, D H; Cohen, M E; Friedman, H S et al. (2000) Carboplatin is effective therapy for young children with progressive optic pathway tumors: a Pediatric Oncology Group phase II study. Neuro Oncol 2:213-20
Pullen, J; Shuster, J J; Link, M et al. (1999) Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study. Leukemia 13:1696-707
Borowitz, M J; Rubnitz, J; Nash, M et al. (1998) Surface antigen phenotype can predict TEL-AML1 rearrangement in childhood B-precursor ALL: a Pediatric Oncology Group study. Leukemia 12:1764-70
Camitta, B M; Pullen, J; Murphy, S (1997) Biology and treatment of acute lymphocytic leukemia in children. Semin Oncol 24:83-91
Martin, P L; Look, A T; Schnell, S et al. (1996) Comparison of fluorescence in situ hybridization, cytogenetic analysis, and DNA index analysis to detect chromosomes 4 and 10 aneuploidy in pediatric acute lymphoblastic leukemia: a Pediatric Oncology Group study. J Pediatr Hematol Oncol 18:113-21

Showing the most recent 10 out of 23 publications